Overall, our present results suggest that nesfatin-1 is an anti-inflammatory adipokine, which may present an additional therapeutic target for protection against the detrimental sequelae of the chronic pro-inflammatory state noted in obesity. This evidence concerns the gene NUCB2 and obesity due to melanocortin 4 receptor deficiency.